Omalizumab for Bullous Pemphigoid Patients With Comorbidities
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Omalizumab: An Underutilized Treatment Option in Bullous Pemphigoid Patients With Co-morbidities
J Eur Acad Dermatol Venereol 2021 Mar 16;[EPub Ahead of Print], D De, A Kaushik, S Handa, R Mahajan, E SchmidtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.